Channing Global Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $680K | Sell |
9,724
-181
| -2% | -$12.6K | 0.44% | 31 |
|
|
2025
Q1 | $728K | Sell |
9,905
-326
| -3% | -$24K | 0.5% | 29 |
|
|
2024
Q4 | $670K | Buy |
10,231
+4,367
| +74% | +$286K | 0.45% | 32 |
|
|
2024
Q3 | $457K | Sell |
5,864
-684
| -10% | -$53.3K | 0.39% | 36 |
|
|
2024
Q2 | $511K | Sell |
6,548
-4
| -0.1% | -$312 | 0.43% | 38 |
|
|
2024
Q1 | $444K | Sell |
6,552
-97
| -1% | -$6.57K | 0.38% | 36 |
|
|
2023
Q4 | $448K | Sell |
6,649
-847
| -11% | -$57K | 0.35% | 37 |
|
|
2023
Q3 | $508K | Buy |
7,496
+1,254
| +20% | +$84.9K | 0.49% | 35 |
|
|
2023
Q2 | $447K | Buy |
6,242
+347
| +6% | +$24.8K | 0.45% | 38 |
|
|
2023
Q1 | $409K | Sell |
5,895
-3,302
| -36% | -$229K | 0.45% | 35 |
|
|
2022
Q4 | $624K | Sell |
9,197
-329
| -3% | -$22.3K | 0.72% | 30 |
|
|
2022
Q3 | $522K | Hold |
9,526
| – | – | 0.66% | 29 |
|
|
2022
Q2 | $629K | Sell |
9,526
-534
| -5% | -$35.3K | 0.68% | 32 |
|
|
2022
Q1 | $667K | Buy |
10,060
+210
| +2% | +$13.9K | 0.65% | 29 |
|
|
2021
Q4 | $574K | Buy |
+9,850
| New | +$574K | 0.54% | 28 |
|